Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

investorenquiries@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

Cancer Therapeutics Research

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

PhamAust Webinar

Category: News & Announcements 2022By PharmAust 17/11/2022

Related posts

Fireside chat with Dr Kim
23/12/2022

PharmAust Canine Trial Update
20/12/2022

PharmAust Receives R&D Tax Incentive Refund
12/12/2022

MND Trial Completes Enrolment of First Patient Cohort
02/12/2022

PhamAust AGM 2022
11/11/2022

PharmAust doses first patient with MPL in motor neurone disease trial
03/10/2022

Recent Articles

Chief Executive Officer Appointment
28/08/2023
Additional Phase 1 data suggest MPL may inhibit MND
22/08/2023
Cohort 3 Pharmacokinetics in MND Patients Completed
09/08/2023
Appendix 4C and Quarterly Update
31/07/2023

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

PharmAust Follow

PharmAust is a clinical-stage biotech company developing drug discovery IP to treat cancer, viral and neurological diseases. ASX: $PAA FSE: $ECQ

PharmAust @pharmaust ·

4 Sep

Great spread on Louie the Beagle in @AustVetMag Australian Veterinarian Magazine - Spring Issue

https://simplebooklet.com/theaustralianveterinarianmagazine_spring_2023_issue21

Reply on Twitter 1698509346102010223 Retweet on Twitter 1698509346102010223 2 Like on Twitter 1698509346102010223 9 Twitter 1698509346102010223

PharmAust @pharmaust ·

2 Sep

PharmAust CEO Dr Michael Thurn spoke with @Biotech_Buzz from @StocksDownUnder and @PSR_Insights about the clinical success with our flagship drug, Monepantel (MPL)

🎥 https://youtu.be/oCfvzseRDxQ?si=iBZu_GMBIg5oSiMX

Reply on Twitter 1697769500807176530 Retweet on Twitter 1697769500807176530 2 Like on Twitter 1697769500807176530 13 Twitter 1697769500807176530

PharmAust @pharmaust ·

29 Aug

New CEO to take the helm as PharmAust progresses clinical studies

Reply on Twitter 1696342181496443106 Retweet on Twitter 1696342181496443106 2 Like on Twitter 1696342181496443106 7 Twitter 1696342181496443106

Load More

Copyright © 2023 PharmAust. All rights reserved.

nil

Website Design & Digital Marketing Perth by Total Click Solutions